143 related articles for article (PubMed ID: 34296976)
21. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
22. Pleiotropic effects of statins in the diseases of the liver.
Janicko M; Drazilova S; Pella D; Fedacko J; Jarcuska P
World J Gastroenterol; 2016 Jul; 22(27):6201-13. PubMed ID: 27468210
[TBL] [Abstract][Full Text] [Related]
23. Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.
Yang YH; Chen WC; Tsan YT; Chen MJ; Shih WT; Tsai YH; Chen PC
J Hepatol; 2015 Nov; 63(5):1111-7. PubMed ID: 26196278
[TBL] [Abstract][Full Text] [Related]
24. Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
Ma X; Sun D; Li C; Ying J; Yan Y
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):533-542. PubMed ID: 28866088
[TBL] [Abstract][Full Text] [Related]
25. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
26. Cirrhosis as new indication for statins.
Bosch J; Gracia-Sancho J; Abraldes JG
Gut; 2020 May; 69(5):953-962. PubMed ID: 32139553
[TBL] [Abstract][Full Text] [Related]
27. Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality.
Vell MS; Loomba R; Krishnan A; Wangensteen KJ; Trebicka J; Creasy KT; Trautwein C; Scorletti E; Seeling KS; Hehl L; Rendel MD; Zandvakili I; Li T; Chen J; Vujkovic M; Alqahtani S; Rader DJ; Schneider KM; Schneider CV
JAMA Netw Open; 2023 Jun; 6(6):e2320222. PubMed ID: 37358849
[TBL] [Abstract][Full Text] [Related]
28. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
Tzefos M; Olin JL
J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148
[TBL] [Abstract][Full Text] [Related]
29. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
[TBL] [Abstract][Full Text] [Related]
30. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis.
Liu B; Yi Z; Guan X; Zeng YX; Ma F
Breast Cancer Res Treat; 2017 Jul; 164(1):1-11. PubMed ID: 28432513
[TBL] [Abstract][Full Text] [Related]
31. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.
Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y
Turk J Gastroenterol; 2022 Feb; 33(2):136-144. PubMed ID: 35115293
[TBL] [Abstract][Full Text] [Related]
32. A prospective study of hepatic safety of statins used in very elderly patients.
Guo M; Zhao J; Zhai Y; Zang P; Lv Q; Shang D
BMC Geriatr; 2019 Dec; 19(1):352. PubMed ID: 31842780
[TBL] [Abstract][Full Text] [Related]
33. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
Sanders RD; Nicholson A; Lewis SR; Smith AF; Alderson P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009971. PubMed ID: 23824754
[TBL] [Abstract][Full Text] [Related]
34. Therapy. Statins and liver disease: from concern to 'wonder' drugs?
Bosch J; Forns X
Nat Rev Gastroenterol Hepatol; 2015 Jun; 12(6):320-1. PubMed ID: 25963509
[TBL] [Abstract][Full Text] [Related]
35. Statins in liver cirrhosis in a developing country: benefits overweigh the risk?
Gonzáles Yovera JG; Concepción-Zavaleta MJ; Moreno Marreros DM; Armas Flórez CD
Expert Opin Drug Saf; 2020 Dec; 19(12):1651-1652. PubMed ID: 33047634
[No Abstract] [Full Text] [Related]
36. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.
Athyros VG; Boutari C; Stavropoulos K; Anagnostis P; Imprialos KP; Doumas M; Karagiannis A
Curr Vasc Pharmacol; 2018; 16(3):246-253. PubMed ID: 28676019
[TBL] [Abstract][Full Text] [Related]
37. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
[TBL] [Abstract][Full Text] [Related]
38. Statin use and risk of liver cancer: an update meta-analysis.
Shi M; Zheng H; Nie B; Gong W; Cui X
BMJ Open; 2014 Sep; 4(9):e005399. PubMed ID: 25227628
[TBL] [Abstract][Full Text] [Related]
39. Impact of statin use on the prognosis of patients with hepatocellular carcinoma undergoing liver resection: a subgroup analysis of patients without chronic hepatitis viral infection.
Nishio T; Taura K; Nakamura N; Seo S; Yasuchika K; Kaido T; Okajima H; Hatano E; Uemoto S
Surgery; 2018 Feb; 163(2):264-269. PubMed ID: 29167018
[TBL] [Abstract][Full Text] [Related]
40. Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort.
Markova AA; Deterding K; Port K; Bantel H; Manns MP; Cornberg M; Wedemeyer H
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):223-229. PubMed ID: 32282399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]